Mativ (MATV) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 net sales were $523.8 million, down 0.5% year-over-year but up 4.7% sequentially, with gross profit up 14% to $108.9 million due to favorable net selling price versus input cost and higher volumes.
Adjusted EBITDA reached $66.6 million, up 45% sequentially and 13% year-over-year, with margin up 350 bps sequentially and 150 bps year-over-year.
Net loss from continuing operations was $1.4 million ($0.03 per diluted share), a significant improvement from a $14.3 million loss in Q2 2023.
Performance was driven by favorable net selling price versus input cost, especially in the SAS segment, and operational efficiencies.
Organizational realignment in Q1 2024 resulted in two new segments: Filtration & Advanced Materials (FAM) and Sustainable & Adhesive Solutions (SAS).
Financial highlights
Gross margin improved to 20.8% from 18.1% year-over-year; operating profit was $10.5 million, flat year-over-year.
Free cash flow for Q2 was $36.8 million; year-to-date operating cash flow was $33.1 million.
Net debt at quarter-end was $1.003 billion, with available liquidity of $436 million.
Interest expense increased to $18.4 million in Q2 2024, up 12% year-over-year due to higher average debt and rates.
Adjusted EPS was $0.34, up from $0.32 prior year.
Outlook and guidance
Management expects continued year-over-year adjusted EBITDA improvement for the remainder of 2024.
Net sales for the second half of 2024 expected to be in line with Q2, with normal year-end seasonality.
Q3 EBITDA expected to be similar to Q2, except for ~$2 million in additional annual outage expenses.
Dividend policy will be assessed in light of strategy, cash generation, and debt levels; a $0.10/share dividend was declared for Q3 2024.
2024 full-year capital expenditures planned at ~$60 million; interest expense ~$75 million; D&A ~$100 million.
Latest events from Mativ
- Operational transformation and targeted investments drive growth and margin expansion.MATV
Investor presentation25 Mar 2026 - Annual meeting to vote on directors, auditor, compensation, and equity plan amendment.MATV
Proxy Filing17 Mar 2026 - Proxy covers director elections, auditor ratification, compensation, and equity plan amendment.MATV
Proxy Filing17 Mar 2026 - Record free cash flow and EBITDA gains achieved despite market headwinds and goodwill impairment.MATV
Q4 202519 Feb 2026 - Adjusted EBITDA up 10% on flat sales; SAS growth offsets FAM headwinds amid restructuring.MATV
Q3 202416 Jan 2026 - SaaS/SAS growth and cost actions offset FAM headwinds, supporting 2025 profit improvement.MATV
Q4 202423 Dec 2025 - All proposals passed, including director election and equity plan amendment; no questions raised.MATV
AGM 202523 Dec 2025 - Board recommends voting FOR all proposals, with focus on governance, compensation, and ESG.MATV
Proxy Filing2 Dec 2025 - Annual meeting to vote on director election, auditor ratification, pay, and equity plan.MATV
Proxy Filing2 Dec 2025